Known benefits and unknown risks of active surveillance of cervical intraepithelial neoplasia grade 2

KD Lycke, LK Petersen, PE Gravitt… - Obstetrics & …, 2022 - journals.lww.com
Financial Disclosure Anne Hammer has received a speaker's fee from AstraZeneca,
Denmark, and has received reagents at reduced cost from Roche Diagnostics, Denmark …

Performance of HPV E4 and p16INK4a biomarkers in predicting regression of cervical intraepithelial neoplasia grade 2 (CIN2): protocol for a historical cohort study

RK Damgaard, D Jenkins, MN De Koning… - BMJ open, 2022 - bmjopen.bmj.com
Introduction Cervical intraepithelial neoplasia grade 2 (CIN2) represents a spectrum of
lesions with variable progression and regression. Pathological diagnosis of CIN2 is …

“I feel reassured, but there is no guarantee.” How do women with a future childbearing desire respond to active surveillance of cervical intraepithelial neoplasia grade …

J Hansen, P Kirkegaard, B Folmann… - Acta Obstetricia et …, 2022 - Wiley Online Library
Abstract Introduction In Denmark, women with a future childbearing desire diagnosed with
cervical intraepithelial neoplasia grade 2 (CIN2) are recommended active surveillance …

[PDF][PDF] From Diagnosis to Treatment: Exploring the Latest Management Trends in Cervical Intraepithelial Neoplasia

S Gupta, N Nagtode, V Chandra, K Gomase - Cureus, 2023 - cureus.com
Cervical intraepithelial neoplasia (CIN) stands as a precancerous condition with the
potential to progress to invasive cervical cancer. This comprehensive review explores the …

[HTML][HTML] Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus–vaccinated and unvaccinated women: a population-based cohort …

L Krog, KD Lycke, J Kahlert, TH Randrup… - American journal of …, 2024 - Elsevier
Background Many countries have implemented active surveillance (ie, leaving the lesion
untreated) as an option among younger women with cervical intraepithelial neoplasia grade …

[HTML][HTML] Цервикальные интраэпиталиальные неоплазии II степени: эффективность противовирусной терапии

ОП Виноградова, НА Андреева, ОИ Артёмова… - Доктор. Ру, 2022 - cyberleninka.ru
Цель исследования: оценка эффективности применения противовирусного препарата
при лечении ВПЧ-ассоциированной цервикальной интраэпителиальной неоплазии …

Untreated cervical intraepithelial neoplasia grade 2 and subsequent risk of cervical cancer: population based cohort study

KD Lycke, J Kahlert, LK Petersen, RK Damgaard… - bmj, 2023 - bmj.com
Objective To describe the long term risk of cervical cancer in women with untreated (that is,
undergoing active surveillance) or immediately treated cervical intraepithelial neoplasia …

[HTML][HTML] Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in …

S Gori, H Frayle, A Pagan, M Soldà… - Family Medicine and …, 2024 - ncbi.nlm.nih.gov
Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised
cervical cancer screening programmes: a multicentre study in Italy - PMC Back to Top Skip to …

[HTML][HTML] An Updated Analysis of the Impact of HPV Vaccination Based on Long-term Effectiveness in the Netherlands

J Luttjeboer, J Simons, T Westra, J Wilschut… - Infectious diseases and …, 2023 - Springer
Introduction Vaccination against human papillomavirus (HPV) is considered the most
effective strategy to protect women from cervical cancer. Three HPV vaccines are currently …

Insights into Automated Diagnosis of Cervical Cancer

A Gaikwad, S Shinde, N Bhuta… - 2023 7th International …, 2023 - ieeexplore.ieee.org
The cervix is the last part of the uterus where cervical cancer usually develops. Identification
of the cervical cells can be very taxing owing to their complexity of morphological changes in …